ME Licensing News

Department of Health – Abu Dhabi launches Declaration on Longevity and Precision Medicine

The Department of Health – Abu Dhabi (DoH) has launched a groundbreaking Declaration on Longevity and Precision Medicine at Abu Dhabi Global Health Week 2025, marking a milestone in efforts to transform healthcare delivery and research worldwide.

As the first initiative of its kind, and developed in collaboration with leading international health organisations, academic institutions, and industry pioneers, the declaration establishes key principles to accelerate the advancement of precision medicine and longevity science.

The signing was led by DoH and included M42, Masdar City, PureHealth, Illumina, NYU Abu Dhabi, the University of Pennsylvania, Aldar, Children’s National Hospital, Burjeel, the Children’s Hospital of Philadelphia, and the Institute for Healthier Living Abu Dhabi (IHLAD).

His Excellency Mansoor Ibrahim Al Mansoori, Chairman of DoH, said: “Healthy populations lead to healthy communities, stronger social cohesion, and fuel economic growth. This declaration unites global leaders to harness emerging technologies responsibly and deliver the benefits of precision medicine to all. Because health knows no boundaries, we are working together towards actionable and long-term solutions.”

Developed in collaboration with experts worldwide, the declaration aims to drive the adoption of personalised care and promote research into extending healthy lifespans. It highlights the urgency of addressing the widening healthspan-lifespan gap, which currently stands at nearly a decade globally.  

The declaration comes at a critical time as the World Health Organization projects the global population aged 60 and older will double to 2.1 billion by 2050. Concurrently, the precision medicine market is expected to grow from US$81 billion in 2023 to more than US$175 billion by 2030.

The United Arab Emirates is a regional and global leader in the longevity market, driven by pioneering regulatory frameworks, investments in precision medicine, and groundbreaking initiatives, such as the world’s first licensed Healthy Longevity Medicine Centre. The UAE's longevity market is estimated to reach US$32 billion by 2026, up from US$19 billion in 2020.

The declaration outlines bold commitments to advance longevity science, artificial intelligence, diagnostics, and personalised therapeutics. It sets forth six key pillars: advancing research and innovation, enhancing collaboration and knowledge-sharing, investing in education and workforce development, advocating for supportive policy and regulation, upholding ethics and responsible practices, and engaging the public about longevity research and its implications for health and society.

PwC Middle East, a strategic partner in the initiative, highlighted the global significance of the declaration in advancing global healthcare priorities.

Lina Shadid, Health Industries Leader, PwC Middle East, said: "The declaration on longevity and precision medicine provides a global blueprint for integrating AI, genomics, and precision healthcare into mainstream medical practice and within the health ecosystem, to accelerate the adoption of life-changing medical innovations worldwide.

“The declaration reflects Abu Dhabi’s ongoing commitment to shaping the future of health through knowledge-sharing, investment in research, and the integration of emerging technologies. By convening global experts and institutions, DoH is ushering in a new era of precision medicine —one that prioritises personalised and preventative care, and enhances quality of life for populations worldwide.”

Governments, health organisations and relevant stakeholders worldwide are encouraged to sign the declaration.

ADGHW 2025 is a major government initiative from DoH and serves as a platform for innovation and collaboration under the theme Towards Longevity: Redefining Health and Well-being. It places a strong emphasis on community-driven health and wellbeing, with a proactive approach centred around preventive, personalised, and holistic care.

Link/Sources:  HERE!

Cleveland Clinic Abu Dhabi performs world’s first robotic-assisted, transcontinental ultrasound focal therapy procedure for prostate cancer

  Cleveland Clinic Abu Dhabi, part of the M42 group, has performed the world’s first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer in collaboration with experts from Cleveland Clinic in US. Focal therapy is a non-invasive treatment that precisely targets a specific section of the prostate using ultrasound beams, eliminating the need for major surgery or radiation. The Focal-One system enhances this approach with a robotic arm that ensures precise and controlled ultrasound delivery.

The innovative surgery enabled real-time collaboration between Dr Ruben Olivares, Urologist in the Glickman Urological Institute at Cleveland Clinic, supporting remotely from Ohio, and Dr Waleed A Hassen, Department Chair of Urology at Cleveland Clinic Abu Dhabi, who managed the on-site procedural execution. Lasting approximately one hour, the remote procedure was completed successfully without complications, demonstrating the transformative potential of advanced technology in expanding access to specialised care.

The remote procedure, powered by cutting-edge technology and robust communication networks, offers unparalleled access to specialised surgical expertise, even in remote or underserved regions. By combining local and global expertise, it addresses critical gaps in healthcare equity and training while enabling minimally invasive treatment options, such as focal therapy for prostate cancer. However, widespread access to such advanced procedures remains a significant challenge in many parts of the world.

Hasan Jasem Al Nowais, Chairman of Cleveland Clinic Abu Dhabi, said: “This innovative remote procedure is a remarkable feat that presents the possibility to manage complex care needs across borders and close global health inequities. We were delighted to have partnered with our colleagues in the US to set a new standard for transcontinental healthcare.”  

Her Excellency Dr Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH), said: "Abu Dhabi is rapidly evolving towards establishing one of the world’s most intelligent and efficient healthcare systems. Our progress is powered by advanced infrastructure and innovation-driven regulatory frameworks, which enhance healthcare quality and accessibility. Cleveland Clinic Abu Dhabi’s achievements mark another milestone in our journey of healthcare excellence, showcasing the sector’s commitment to pioneering medical solutions and cutting-edge technologies. This success strengthens our local and global partnerships, reaffirming the emirate’s dedication to safeguarding the health and wellbeing of our community and beyond."

Dr Georges-Pascal Haber, CEO of Cleveland Clinic Abu Dhabi, said: “Cleveland Clinic Abu Dhabi has always been at the forefront of integrating advanced technology with world-class care. Remote procedures represent the future of healthcare, pushing the boundaries of what can be achieved in medicine. This procedure exemplifies our vision of leveraging cutting-edge technology with collaborative expertise to set new benchmarks in patient care. It is exciting to partner with our colleagues in the US to make history and transform patient outcomes on a global scale. The success of this procedure marks a new era in global surgical collaboration. We envision a future where advanced treatments are accessible to patients regardless of location, reducing health disparities and improving outcomes for everyone.”

The journey to this achievement began in October 2023, when Cleveland Clinic Abu Dhabi introduced the Focal One high-intensity focused ultrasound (HIFU) therapy to patients in Abu Dhabi. Focal One represents a novel approach to treating non-metastatic prostate tumours, utilising advanced imaging technology to precisely target cancerous cells. This method enables effective tumour treatment while minimising the risk of side effects.

Dr Waleed A Hassen, Department Chair of Urology at Cleveland Clinic Abu Dhabi, said: "There are many ways to treat prostate cancer, and one of the options is focal therapy. It’s a non-invasive procedure where we use a robotically controlled arm to deliver treatment. Once the treatment plan is in place, the machine delivers it precisely. This is proof of principle that we can contour the prostate, design the plan, and execute it remotely. The procedure typically takes about an hour, with the Focal-one screen visible to both the surgical team and the ultrasound team, ensuring shared expertise.

Dr Ruben Olivares, M.D., Urologist in the Glickman Urological Institute at Cleveland Clinic, said: “We are thrilled to have successfully performed the first-ever transcontinental robotic assisted focal therapy procedure for prostate cancer by working in tandem with our partners at Cleveland Clinic Abu Dhabi. Here at Cleveland Clinic, we use cutting-edge technology, but unfortunately, it's not available in many places throughout the US and in the world. We look forward to expanding the adoption of the latest alternative minimally invasive options and increasing access for patients throughout the world with this first step."

This milestone comes as Cleveland Clinic Abu Dhabi celebrates a decade of excellence in care, making remarkable strides in advancing healthcare through integration of technology. As the hospital continues to explore the potential of remote procedures, the implications stretch far beyond prostate cancer treatment. This success not only opens new pathways for surgical education and collaboration but also drives global accessibility to advanced care.

Link/Sources:  HERE!

UAE Health Council discusses strategic health projects to strengthen UAE's global competitiveness

The UAE Health Council has discussed proposed plans for the future of healthcare in the country, emphasising its commitment to launching strategic and innovative projects that not only enhance healthcare delivery, but also improve service quality, and build a more integrated and sustainable sector.

During a meeting chaired by Awad Saghir Al Ketbi, Director-General of the Dubai Health Authority, on behalf of Abdulrahman bin Mohamed Al Owais, Minister of Health and Prevention, the council reviewed the UAE’s recent achievements in healthcare.

Also present were senior representatives from both public and private health sectors.

The council stressed that it is committed to implementing the directives of the country’s wise leadership to achieve the goals of the "We the UAE 2031" vision as well as the objectives of the Year of Community. “We will continue to support community-focused health initiatives and strategic projects that would promote wellness and encourage healthy lifestyles, thereby contributing to a healthier, more cohesive, and sustainable society,” the council said.

Council members reaffirmed that such strategic projects are part of the UAE’s ongoing efforts to develop a flexible, future-ready health system that meets global standards, strengthens sustainability, boosts the country’s global competitiveness, and enhances the overall quality of life for its people.

During the meeting, the Council discussed a series of innovative health initiatives, including the health cloud project, and the unified licensing project for health professionals across the country.

The meeting also reviewed the latest developments related to establishment of the Emirates Council for Accreditation of Healthcare Entities and the ongoing efforts to create a national centre dedicated to epidemic prevention.

Additionally, the Council was briefed on the latest updates regarding the health professionals’ journey tracking platform, which now includes a fully completed scholarship platform infrastructure. Efforts are currently underway to integrate and establish direct connections with the relevant authorities.

In parallel, the Council discussed efforts to develop regulatory standards for regulating artificial intelligence in the healthcare sector to ensure that AI technologies are deployed in a safe, ethical, and effective manner—while aligning with international best practices.

The Council commended the UAE's excellence in health legislation, in light of the recently approved Executive Regulations for Organ and Human Tissue Donation and Transplantation by the cabinet as well as the new national policy endorsed to combat health risks, strengthen national preparedness in areas such as prevention, response, recovery, and overall health risk management.

This policy will not only improve the efficiency of the health system and facilities but also help build national capacities. Supported by international partnerships and scientific research, these efforts aim to boost the UAE's competitiveness in this vital sector.

The Health Council plays a pivotal role in developing a roadmap for the future of healthcare in the UAE by foreseeing global developments, driving innovation, and fostering coordination between federal and local health authorities and the private sector.

It is responsible for developing forward-looking health policies and legislation, enhancing integration across the sector, and ensuring alignment with international best practices. Through these efforts, the Council doesn’t only contribute to promoting sustainability and strengthening the country’s competitiveness in global health indicators but also to building a robust, resilient, and world-class healthcare system.

Link/Sources:  HERE!

Dr. Soliman Fakeeh Hospital in Jeddah is among the top three 5-star hospitals in MENA

Achieving a 5-star rating in the "Global Hospital Rating" by Newsweek and Statista.

Jeddah – Dr. Soliman Fakeeh Hospital in Jeddah continues to strengthen its leadership position in the healthcare sector in Saudi Arabia by achieving a 5-star rating in the "Global Hospital Rating" by Newsweek and Statista. With this accomplishment, the hospital rates among the top 3 hospitals in the Middle East and North Africa to receive this prestigious global recognition.

The “Global Hospital Rating” is based on five key categories: Provision of Care, for Quality of medical services, staffing, and patient management. Timeliness of Care, for Waiting times and service efficiency. Patient Experience & Safety, for Hygiene, infection prevention, and patient satisfaction. IT & Healthcare Technology, for Digital infrastructure and medical technology. Employer Attractiveness, for Staff development and workplace environment.

Data was collected and performance indicators in these areas were analyzed and compared with international standards by the globally renowned firm, "Statista."

As part of its ongoing achievements, the hospital has recently maintained its title as the Best Private Hospital in the Saudi Arabia for the fourth consecutive year. Additionally, it ranked second among all hospitals, both government and private, following King Faisal Specialist Hospital and Research Center in Riyadh, according to the 2025 Newsweek World's Best Hospitals ranking.

Link/Sources:  HERE!

Aster Hospital Mankhool and Medcare Hospital Al Safa recognized for medical excellence at the Dubai Quality Group Award

Honored for Advancing Clinical Excellence, Patient Safety, and Innovation in Healthcare across the UAE and MENA Region

Dubai, UAE – Aster Hospital Mankhool and Medcare Hospital Al Safa, part of Aster DM Healthcare—the leading integrated healthcare provider in the GCC—have been recognized for their commitment to quality and innovation in healthcare at the prestigious Dubai Quality Group Award held recently. The two hospitals achieved top honors, with Aster Hospital Mankhool securing the Gold category and Medcare Hospital Al Safa earning the Silver category at the 1st Cycle of the Medical Excellence MENA Award, organized by the Medical Excellence Subgroup of Dubai Quality Group.

Under the patronage of His Highness Sheikh Ahmed bin Saeed Al Maktoum, the Medical Excellence Subgroup of Dubai Quality Group launched this esteemed award to promote a culture of excellence, innovation, and safety in the healthcare sector across the UAE, GCC, and MENA region. The award recognizes institutions that set benchmarks in quality healthcare delivery, aligning with globally accepted best practices and fostering patient-centric care.

The award ceremony, held at the Habtoor Ballroom, Al Habtoor Palace, was attended by His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of Dubai Civil Aviation Authority, Chairman of Dubai Airports and Chairman and Chief Executive of Emirates Airline and Group, along with Dr. Hazza Khalfan Alnuaimi, Chairman of Dubai Quality Group. The event, hosted by Mrs. Sameera Mohammed, General Manager of Dubai Quality Group, brought together over 600 dignitaries, state and regional leaders, executive presidents, and representatives from local and international media, celebrating outstanding contributions to healthcare excellence.

Speaking on this remarkable achievement, Dr. Malathi Arshanapalai, Group Chief Medical Officer and Group Chief Quality Officer, Aster DM Healthcare, said, "This accolade reinforces our mission to set new benchmarks in clinical excellence, safety, and patient experience across our hospitals. At Aster, there has been a paradigm shift in the way we measure clinical excellence – moving from a provider perspective to the receiver’s perspective. In simple terms, we capture our clinical outcomes as determined by the patients’ reporting outcomes of care (PROM – Patient Reported Outcome Measures) and patients’ reporting their experience of care (PREM – Patient Reported Experience Measures). This ensures great value add to the patients, which was well appreciated during the assessment."

Dr. Arshanapalai added, "Aster Hospital Mankhool’s recognition in the Gold category and Medcare Al Safa’s Silver category win are a testament to the dedication of our teams in delivering high-quality, patient-centric care. These achievements highlight our unwavering commitment to adopting best practices, ensuring optimal healthcare outcomes, and continuously innovating to meet the evolving needs of our patients."

Echoing this sentiment, Dr. Sherbaz Bichu, CEO of Aster Hospitals and Clinics, UAE, Oman & Bahrain, emphasized the significance of this recognition, stating, 'Receiving the Dubai Quality Group Award is a testament to Aster’s unwavering commitment to delivering world-class healthcare services. Aster Hospital Mankhool’s recognition in the Gold category reflects our dedication to clinical excellence, patient safety, and continuous innovation. Our highly skilled professionals and the clinical expertise of our doctors have won us this recognition, topped with rigorous protocols ensuring the best possible clinical outcomes. Above all, compassion and empathy are our core values, and today we stand proud of this accolade. This honor fuels our passion to elevate healthcare standards and enhance patient experiences across the region.”

Adding to the celebration, Dr. Shanila Laiju, Group CEO of Medcare Hospitals and Medical Centres, stated, "Medcare Hospital Al Safa’s Silver category win highlights our commitment to medical excellence and a patient-first approach. We will continue to implement advanced medical practices and innovations that enhance patient care and strengthen the UAE’s position as a global healthcare hub."

The Medical Excellence MENA Award under Dubai Quality Group was established to promote the UAE as a health tourism hub, foster a competitive healthcare environment, ensure safe and high-quality medical care, and integrate ESG (Environmental, Social, and Governance) principles into healthcare institutions. The award aligns with the UAE’s vision of elevating healthcare standards and promoting sustainable excellence in the industry.

In addition to these accolades, Aster DM Healthcare has recently been honored with the Dubai Quality Appreciation Award, reinforcing its position as a leading healthcare provider committed to excellence. Aster Hospital Mankhool has also achieved accreditation from the Emirates International Accreditation Centre, further validating its commitment to maintaining the highest standards in patient safety and healthcare delivery. Medcare Hospital Al Safa continues to raise the bar with its Joint Commission International (JCI) reaccreditation, emphasizing its adherence to global best practices in healthcare.

The recognition of Aster Hospital Mankhool and Medcare Hospital Al Safa at the Dubai Quality Group Award further solidifies their position as leaders in delivering exceptional healthcare services. Their dedication to medical excellence, patient safety, and quality care continues to set new benchmarks for the region’s healthcare landscape, reinforcing their commitment to innovation and world-class healthcare delivery.

About Aster DM Healthcare FZC in GCC

Founded in 1987 by Dr. Azad Moopen, Aster DM Healthcare is a leading integrated healthcare provider, with a strong presence across all six countries in the GCC. Aster is committed to the vision of providing accessible and high-quality healthcare, from primary to quaternary services, with its promise of “We will treat you well”. The organisation’s robust integrated healthcare model includes 15 hospitals, 122 clinics, and 313 pharmacies in GCC serving all segments of the society through three differentiated brands: Aster, Medcare and Access. Aster consistently adapts to meet the evolving needs of patients, ensuring access to quality healthcare through both physical and digital channels which is exemplified with the launch of the region's first healthcare super app, myAster.

Link/Sources:  HERE!

Experts also said a structured approach that treats employees with respect, goes a long way in maintaining trust and keeps bridges open for the future during layoffs

HR professionals in the UAE are urging companies to explore redeploying existing employees to other departments before resorting to layoffs.

This comes amid a surge in global and local job cuts since the start of 2025. Despite the ongoing recovery of the regional economy from the pandemic, job security remains uncertain.

Industries such as technology, aviation, media and retail have faced significant downsizing this year. Worldwide, major corporations, including Amazon, Boeing and Spirit Airlines, have announced staff reductions extending into the year.

Meanwhile, when Khaleej Times reached out to recruiters in the UAE, they emphasised the importance of strong communication, noting that employers who approach redundancies with openness, honesty and empathy, tend to manage the process more effectively for everyone involved.

Connect with recruitment agencies, stay active on LinkedIn

Nicki Wilson, Executive Director, Genie Recruitment said, “Internal redeployment should always be considered before resorting to layoffs. If an employee’s role is no longer viable but they have valuable skills that could benefit another department, redeployment can be a win-win situation.

"HR can play a crucial role in supporting employees beyond their tenure at a company by offering practical assistance, such as connecting them with recruitment agencies or career coaches, making a significant difference. Providing access to job search platforms and resume-building workshops could also prove to be useful in such situations.”

Job cuts in November 2024 totalled 57,727, marking a 3.8 per cent rise from October 2024, as per a report from Challenger, Gray & Christmas Inc.

Wilson stressed many professionals underestimate the power of LinkedIn until they need it. She emphasised having a strong profile and an active presence on such platforms can significantly improve job prospects.

She added, “Continuous learning and development should be a priority, not just for employees but for companies as well. The workplace is evolving at an unprecedented rate and those who fail to keep up with industry trends risk becoming redundant, sometimes literally,” added Wilson. “Employees who actively seek out new skills, build their networks and stay informed about market trends are far better equipped to navigate career uncertainties.”

Follow a clear, structured approach

Experts also pointed out that a clear, structured approach that treats employees with respect, goes a long way in maintaining trust, even in difficult times, and keeps bridges open for the future.

Aws Ismail General Manager, Marc Ellis, Dubai, said, “I think layoffs are tough for everyone, but the way companies handle them makes all the difference. I believe companies should explore all options before layoffs, and when decided, transparency is key. Employees deserve honest communication about why layoffs are happening and how decisions are made. The worst thing a company can do is leave people in the dark or let rumours take over.”

Severance packages

Ismail also added, “Internal redeployment is an option that’s often overlooked. Instead of letting go of valuable talent, businesses should explore whether employees can be retrained for other roles within the company. When layoffs are unavoidable, severance packages should have a balance — giving employees enough financial support to move forward while ensuring business sustainability.”

Specialists also emphasised layoffs, while sometimes unavoidable, can serve as a turning point for employees, allowing them to reassess their careers and explore new opportunities.

Nadeem Ahmed, Senior HR Officer at Hidayath Group, also added, “HR should focus on identifying the employee's skill set and explore opportunities to move them to other departments, such as through internal job postings. Additionally, they should provide a severance package which can ease the transition and provide a safety net for employees as they search for new roles.”

Link/Sources:  HERE!

Layoffs are a challenging and emotional experience.

And in a region where employment is often directly linked to residency and social benefits, the consequences of losing a job can go beyond financial instability. For many expats, losing a job not only affects their livelihood but also it can affect their sense of identity and self-worth.

Ilham Darkaoui, a 36-year-old Belgian expat who came to Dubai in November 2017, recalled how the constant rounds of restructuring and layoffs at her job in the tech industry took a toll on her mental health.

“In the last three years, the number of layoffs increased to two-three times per year,” she said. Darkaoui always suspected that her job could be at risk because her role was not specific to Dubai. The uncertainty of “Am I next?” was overwhelming.

“I was constantly messaging my manager, asking if our team would be affected. There were rumours floating around all the time and nothing was certain. Working in such a precarious environment was mentally exhausting,” she recalled.

This constant fear of job loss took a toll on Darkaoui’s health. “I was nervous all the time,” she explained. “I barely slept because I was working around the clock to accommodate my stakeholders and management in two different time zones. I was trying to stay relevant for the company by showing flexibility in working hours. I made poor eating choices because delivery was the fastest option. My body actually broke out in hives because of nerves and stress. I wasn’t taking care of myself mentally or physically.”

But Darkaoui couldn’t escape the inevitable. She was ultimately fired in November 2024. Ironically though, she said: “When I got the news that I was laid off, it was actually a relief.

“For so long I identified who I was and my value as a person in relation to my job. But now that was done, I could finally take the time to do the deep work and find out who I really am.”

Without minimising the very real effects that Darkaoui’s experiences had on her mental health, she still considered herself lucky. Her residency was not affected by her job loss, and her company did offer severance.

But that’s not the case for many in the region. Misha Akbar, an HR professional and founder of Sama Health, a mental health service provider tailored to South Asians, underscored the pressure and systemic challenges facing the majority of workers in the Gulf. “In most of the GCC countries, your residency is still linked to your employer,” she said. “If you lose your job, it’s not just about finding a new role; it’s about your visa status.”

The lack of social security and severance benefits in many parts of the Gulf, especially in high-cost regions like Dubai, also means that workers face immediate financial instability. “In other parts of the world, severance is standard,” she said. “But in the Gulf, that’s not guaranteed and many people don’t have the luxury of time or savings to be able to relax. Finding a new job immediately becomes paramount.”
Fighting the odds

And according to her, the worst time to be looking for a job is when you’ve already lost your gig, and have everything depending on it. “The job market in Dubai is highly competitive. When you go on LinkedIn and see how many people have applied for a role, it’s in the thousands. The odds are instantly stacked against you. With so many qualified applicants vying for the same positions, it’s easy to lose confidence.”

She noted that searching for a new job after being terminated can lead to feelings of isolation and helplessness. However, Akbar advised that it’s important to not let these feelings undermine one’s self-worth.

“Job loss can be devastating, but it’s important to realise that it doesn’t define you,” she said. “You have to see yourself as a person with valuable skills, not just as an employee at a company.”

That’s why in her role coaching others, Akbar emphasises the importance of preparation. “Even if you have a well-paying job, you should always be looking for other opportunities,” she said.

While this can create an undercurrent of anxiety, Akbar believes it’s all in how you frame the narrative.

“Network and invest in learning new skills as a tool for personal and professional growth, not because you’re worried about your job per se. It’s more about not keeping all of your eggs in one basket. Look at what skills are in demand and learn them. Connect with people on LinkedIn when you’re already employed and build a genuine connection based on shared interests and learning. If you should experience job loss, this foundation of upskilling and networking will give you a head start in your job search.”

These investments also foster confidence and lead to feeling empowered, which has a positive effect on your mental health. And confidence and empowerment lead to resilience — if you’ve laid the foundation, it can soften the blow of job loss because you’ll feel more prepared for what comes next.

This approach is critical, especially for expats in the Gulf who may find themselves vulnerable to the whims of the job market and corporate restructuring. “It’s all about mindset,” Akbar reiterated. “Accept that your value doesn’t lie solely in your job title. If you invest in yourself because you know that you are more than just your profession, it becomes easier to weather the ups and downs of career challenges.”

Akbar’s tips on how to support someone who has lost their job.

Avoid saying:

  Don’t worry, you’ll find something soon.

  You didn’t like that job anyway.

  At least you have savings.

  Everything happens for a reason.

Instead, say:

  I’m so sorry you’re going through this. How are you feeling today?

  This must be tough. Let me know if there’s anything you need.

  I’m here for you — whatever you need, whenever you’re ready.

What really helps:

  A quick message like, “Thinking of you today — no need to reply, just wanted to check in.”

  Offering practical support: “If you’d like, I can help review your CV or connect you with someone in my network.”

Supporting someone through job loss doesn’t mean having all the answers. It’s about showing up — listening, holding space, and reminding them they don’t have to face it alone.

In times of difficulty, your presence and willingness to support can make all the difference.
Link/Sources:  HERE!

Qatar: HMC sees over 3mln outpatient visits in 2024

The Outpatient Department recorded 3,198,989 visits in 2024; it includes 1,770,362 visits between July and December 2024, which is an increase by 24% compared to 1,428,627 visits recorded between January and June 2024

Doha, Qatar: The Outpatient Department of Hamad Medical Corporation (HMC) received more than 3 million visits, while its laboratory conducted over 24 million tests, making them the most sought-after services in 2024, according to statistics.

HMC is the main public healthcare provider in Qatar, managing 12 hospitals — nine specialist hospitals and three community hospitals — as well as the Ambulance Service, and Paediatric Emergency Services among others.

Since January 2024, HMC has been releasing monthly statistics from its hospitals and services. According to the data, outpatient services and laboratory tests were the most sought-after services in both the first and second halves of the year. The second half saw an increase in demand for both services.

The Outpatient Department recorded 3,198,989 visits in 2024; it includes 1,770,362 visits between July and December 2024, which is an increase by 24% compared to 1,428,627 visits recorded between January and June 2024.

The Department of Laboratory Medicine and Pathology (DLMP) conducted 24,372,843 tests; among it 11,759,079 tests were conducted in the first half of 2024 and 12,613,764 tests between July and December 2024, which is an increase by 7.27 percent.

The Center for Patient Experience and Staff Engagement (CPESE) at HMC is working to improve the Referral and Booking Management System (RBMS) to enhance the outpatient experience by optimising appointment booking, reducing waiting times, and ensuring easier access to care. Meanwhile, DLMP provides the latest diagnostic laboratory services supporting improved diagnosis, treatment, disease management, and prevention.

According to a report released yesterday on total activities across HMC hospitals and services in December 2024, the Outpatient Department received 295,997 visits by patients and 2,100,771 laboratory tests were conducted. A total of 4,142 medical reports were processed.

“HMC provides healthcare services and treatment to tens of thousands of patients each month across all of its hospitals and facilities."

“Here is an insight into the world-class, patient-centred care services delivered in December 2024. Wishing you good health and well-being,” HMC said on X platform.

HMC’s ‘Nesma’ak’ customer service helpline 16060 is the third most sought service in 2024 and it handled more than 1.7 million calls.

Nesma’ak Customer Service supports the patients’ entire journey at HMC through several services.

Its staff are available at all HMC facilities through over 65 help desks by assisting, guiding and answering the patients and visitors’ queries from 6am to 10pm and around the clock at the Hamad General Hospital’s Emergency Department.

HMC’s Emergency Services also provided care to remarkable number of adults and children – a majority of them in life-threatening medical conditions.

In 2024, the Emergency Departments at HMC hospitals received 672,701 patients, and the five Paediatric Emergency Centres of HMC treated 781,595 children. The Ambulance Service received 402,320 calls and recorded 1,887 life-flight air ambulance activations in 2024.

In 2024, all hospitals across the HMC network treated 405,571 inpatients. A total of 25,467 babies were born between February and December 2024 at HMC hospitals.

HMC’s Urgent Consultation Service, which offers telephone consultations for urgent conditions without a prior appointment, received 147,896 calls in 2024.

The National Mental Health Helpline, which provides professional mental health care and support, received 15,501 calls.


Link/Sources:  HERE!

Medlab Middle East looks to the future of laboratories as the market is estimated to reach $473.84mln by 2029

Laboratory technologies are transforming healthcare and proving vital in identifying and treating diseases

Medlab Middle East will spotlight global industry leaders including Abbott, Beckman, Coulter and Randox and will offer 12 CME-accredited conference tracks at the Medlab Middle East Congress
The 24th edition of Medlab Middle East will be held from 3-6 February at the Dubai World Trade Centre

Dubai, United Arab Emirates: The medical laboratory market in the Middle East and Africa (MEA) is on track for remarkable growth, with recent research projecting it to reach USD473.84 million by 2029 at a robust Compound Annual Growth Rate (CAGR) of 12.6%. Against this promising backdrop, Medlab Middle East, taking place from 3-6 February, will bring together medical laboratory professionals and industry leaders to explore the future of laboratories and their transformative impact on healthcare in the region and beyond.

The medical laboratory market is a crucial part of the healthcare industry, providing a wide range of diagnostic and testing services. Laboratories are vital in disease identification, monitoring and treatment decisions, enabling healthcare practitioners to provide accurate and effective patient care.

The demand for healthcare services in the MEA region has increased considerably in recent years due to a rise in chronic and non-communicable illnesses, a growing population and the implementation of mandatory coverage for healthcare and healthcare insurance programmes.

“Now in its 24th edition, Medlab Middle East showcases the forefront of laboratory technology and innovation, attracting global leaders, pioneers, and industry experts. The event offers a premier platform for experiencing groundbreaking discoveries, exploring cutting-edge solutions, and engaging in invaluable networking opportunities,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare.

Medical lab technology provides healthcare practitioners with a comprehensive picture of a patient’s health by improving access to health data and providing people more control over their health. These technologies are enabling faster, more accurate and more personalised diagnosis and treatments, reducing costs, increasing accessibility and enhancing patient outcomes.

Technology has made remarkable advances in recent years to revolutionise healthcare and improve the way physicians detect and treat diseases. Key innovations include Next-Generation Sequencing (NGS), Point-of Care Testing (POCT) and 3D Printing. Artificial Intelligence (AI) and machine learning have also revolutionised medical lab technology by bringing together data analytics and prediction algorithms to offer better diagnosis and improved patient care.

Medlab Middle East will showcase the latest innovations from global laboratory leaders including Abbott, Beckman Coulter, Randox and Sansure. During the event, Sansure will present its latest POCT solution IPonatic III Pro. This device uses advanced magnetic extraction technology, overcoming the limitations of traditional PCR methods to provide fast, reliable analysis.

Meanwhile, Beckman Coulter will showcase the DxC 500 AU Chemistry Analyser which optimises lab operations, and the Dxl 9000 Access Immunoassay Analyser which enables laboratories to meet accelerated demand and take diagnostics to the next level. Randox will introduce the Acusera Smart Range at Medlab Middle East which offers a range of benefits to laboratories including minimising stock management and ordering, reducing inventory and saving time.

Leading the way in driving excellence and innovation in medical laboratories, the Medlab Middle East Congress will feature over 150 world-class international and local speakers during an insightful four-day programme. Delivering 12 CME-accredited conference tracks, the Congress will cover Lab Management, Clinical Chemistry, Lab Quality, Haematology, Clinical Microbiology, Molecular Diagnostics, Blood Transfusion Medicine and Cellular Therapy, Histopathology, Lab Automation, Lab Sustainability and Immunology.

Thought Leadership Forums have been added to the Congress agenda this year which are dedicated to Women’s Health and Precision Medicine. On day two and three of Medlab Middle East, the Global Lab Leaders Breakfast Forum will unite advisers, scientific chairs, international partners and stakeholders in an exclusive dialogue to advance laboratory practices worldwide.

Medlab Middle East 2025 will centre around the theme, ‘Empowering today’s medical labs for tomorrow’s global future’ The key product categories showcased at the event are Disposable, Healthcare/General Services, Imaging, Infrastructure, IT, Laboratory, Medical Equipment and Pharma/Nutrition.

Medlab Middle East is the premier event for the medical laboratory industry, taking place at the Dubai World Trade Centre. The 2024 edition generated a remarkable $670 million in business, solidifying its position as a key player in the global healthcare landscape.


Link/Sources:  HERE!